Targeted delivery of PTX by lactoferrin-modified nanoemulsions for the treatment of glioblastoma
Authors:
- Haiming HuangHHHaiming Huang
- Jiyong PengJPJiyong Peng
- Zhiting GaoZGZhiting Gao
- Yongtong HuangYHYongtong Huang
- Wenyang SongWSWenyang Song
- Wenhao WuWWWenhao Wu
- Song GaoSGSong Gao
- Songsen ChenSCSongsen Chen
- Qingchun XieQXQingchun Xie
- Shu ZhangSZShu Zhang
- Jiu WangJWJiu Wang
Open Access
- 1 December 2025
- journal article
- Published by Elsevier in International Journal of Pharmaceutics: X
- Vol. 10
Abstract
No abstract availableKeywords
Funding Information
- Guangdong Medical Research Foundation (B2020033)
This publication has 45 references indexed in Scilit:
- The protein corona hampers the transcytosis of transferrin-modified nanoparticles through blood–brain barrier and attenuates their targeting ability to brain tumorBiomaterials, 2021
- Lactoferrin, a unique molecule with diverse therapeutical and nanotechnological applicationsInternational Journal of Biological Macromolecules, 2020
- An Overview of Drug Delivery Systems2019
- Quantitation of low concentrations of polysorbates 80 in protein formulations by Coomassie brilliant blueAnalytical Biochemistry, 2019
- Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain gliomaEuropean Journal of Pharmaceutical Sciences, 2017
- Glioma Subclassifications and Their Clinical SignificanceNeurotherapeutics, 2017
- Lactoferrin-coated polysaccharide nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG for treating brain gliomaCarbohydrate Polymers, 2017
- A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's diseaseColloids and Surfaces B: Biointerfaces, 2015
- Overcoming the blood–brain tumor barrier for effective glioblastoma treatmentDrug Resistance Updates, 2015
- Glioblastoma and Other Malignant GliomasJAMA, 2013